It’s a great idea to invest in us – and here’s why
- Poised for long-term growth; building on attractive mega trends in Life Science, Healthcare and Electronics
- Resilient and high-quality cashflow profile; reliable cash generation leveraging multi-industry set up
- Strong M&A track record enhanced by rapid deleveraging
- Bringing innovation faster to patients and customers, contributing to their sustainability efforts
Related News
View All News-
Press Releases
Merck KGaA, Darmstadt, Germany Completes Acquisition of SpringWorks Therapeutics ...
We have closed the acquisition of SpringWorks Therapeutics, Inc., for an enterprise value of $3.4 billion (approximately €3 billion).
2025/07/01
-
Press Releases
Merck KGaA, Darmstadt, Germany, Honors Alán Aspuru-Guzik with the Heinrich ...
The Heinrich Emanuel Merck Award has been bestowed upon Alán Aspuru-Guzik, University of Toronto, in recognition of his groundbreaking innovations.
2025/06/28
-
Press Releases
MilliporeSigma Announces Neoclease as Winner of 2025 North American Advance ...
MilliporeSigma today announced Boston-based biotech startup Neoclease as winner of the 2025 North American Advance Biotech Grant.
2025/06/18
Share Price
Check Share PriceShare Price
Our interactive Share Price Tool provides you with all the information you need. You can retrace our development within the last ten years or follow it in real time – or compare our share price to various indices.
Financials
Read MoreFinancials
Our Financial Reporting Center offers you the opportunity to select from financial data on an annual or quarterly basis.